Celgene (CELG) Tops Q4 EPS by 2c, Offers FY17 Guidance

Celgene (NASDAQ: CELG) reported Q4 EPS of $1.61, $0.02 better than the analyst estimate of $1.59. Revenue for the quarter came in at $2.98 billion versus the consensus estimate of $3.02 billion.

GUIDANCE:

Celgene sees FY2017 EPS of $7.10-$7.25, versus the consensus of $7.13. Celgene sees FY2017 revenue of $13-13.4 billion, versus the consensus of $13.3 billion.

For earnings history and earnings-related data on Celgene (CELG) click here.

You May Also Be Interested In

• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
• Skillsoft (SKIL) Tops Q2 EPS by 14c; Offers Guidance
• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance